Cargando…
The V(H) framework region 1 as a target of efficient mutagenesis for generating a variety of affinity-matured scFv mutants
In vitro affinity-maturation potentially generates antibody fragments with enhanced antigen-binding affinities that allow for developing more sensitive diagnostic systems and more effective therapeutic agents. Site-directed mutagenesis targeting “hot regions,” i.e., amino acid substitutions therein...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8050046/ https://www.ncbi.nlm.nih.gov/pubmed/33859250 http://dx.doi.org/10.1038/s41598-021-87501-7 |
Sumario: | In vitro affinity-maturation potentially generates antibody fragments with enhanced antigen-binding affinities that allow for developing more sensitive diagnostic systems and more effective therapeutic agents. Site-directed mutagenesis targeting “hot regions,” i.e., amino acid substitutions therein frequently increase the affinities, is desirable for straightforward discovery of valuable mutants. We here report two “designed” site-directed mutagenesis (A and B) targeted the N-terminal 1–10 positions of the V(H) framework region 1 that successfully improved an anti-cortisol single-chain Fv fragment (K(a), 3.6 × 10(8) M(−1)). Mutagenesis A substituted the amino acids at the position 1–3, 5–7, 9 and 10 with a limited set of substitutions to generate only 1,536 different members, while mutagenesis B inserted 1–6 random residues between the positions 6 and 7. Screening the resulting bacterial libraries as scFv-phage clones with a clonal array profiling system provided 21 genetically unique scFv mutants showing 17–31-fold increased affinity with > 10(9) M(−1) K(a) values. Among the mutants selected from the library A and B, scFv mA#18 (with five-residue substitutions) and mB(1-3)#130 (with a single residue insertion) showed the greatest K(a) value, 1.1 × 10(10) M(−1). |
---|